✦ LIBER ✦
438 Continued safety and efficacy of adding adefovir dipivoxil (ADV) to ongoing lamivudine (LAM) therapy in compensated chronic hepatitis B (CHB) patients with YMDD variant HBV: 2 year results
✍ Scribed by R. Perrillo; B. Willems; N. Leung; C. Trepo; H.W.L. Hann; G. Lau; W.M. Lee; E. Schiff; T. Wright; S. Scott; M. Woessner; C.L. Brosgart; S. Gardner
- Book ID
- 117373267
- Publisher
- Elsevier Science
- Year
- 2004
- Tongue
- English
- Weight
- 61 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.